September 19, 2022 10:24 AM EDT

Rejection No. 2 for Medexus' decades-old chemo drug; Trevi touts chronic cough data

Kyle LaHucik

Biotech Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

US warns drugmakers against misrepresenting cost of imported products

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?